Nyxoah Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Nyxoah Stock Summary

Nyxoah competes with Femasys, GlucoTrack, Disney, Walmart, and Johnson Johnson. Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium. Nyxoah S is traded on NASDAQ Exchange in the United States.

Nyxoah Key Financial Ratios

Nyxoah Key Balance Sheet Accounts

Nyxoah Key Income Statement Accounts

Nyxoah Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Nyxoah's current stock value. Our valuation model uses many indicators to compare Nyxoah value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nyxoah competition to find correlations between indicators driving Nyxoah's intrinsic value. More Info.Nyxoah is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . As of now, Nyxoah's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nyxoah's earnings, one of the primary drivers of an investment's value.

Nyxoah Systematic Risk

Today, most investors in Nyxoah Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Nyxoah's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Nyxoah growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Nyxoah help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Nyxoah. We use our internally-developed statistical techniques to arrive at the intrinsic value of Nyxoah based on widely used predictive technical indicators. In general, we focus on analyzing Nyxoah Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Nyxoah's daily price indicators and compare them against related drivers.

When running Nyxoah's price analysis, check to measure Nyxoah's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nyxoah is operating at the current time. Most of Nyxoah's value examination focuses on studying past and present price action to predict the probability of Nyxoah's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nyxoah's price. Additionally, you may evaluate how the addition of Nyxoah to your portfolios can decrease your overall portfolio volatility.